Onconic Therapeutics Inc. (KOSDAQ:476060)
20,350
+1,370 (7.22%)
May 21, 2026, 1:20 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 851.97 billion as of May 20, 2026. Its market cap has increased by 198.82% in one year.
Market Cap
851.97B
Enterprise Value
794.78B
Revenue
53.39B
Ranking
n/a
PE Ratio
54.55
Stock Price
20,350.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 851.97B, an increase of 355.82%. That is a compound annual growth rate of 191.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 851.97B | -2.05% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 1.46T |
| Chabiotech | 1.32T |
| Pharmicell | 997.87B |
| GI Innovation | 819.03B |
| GC Corp. | 702.36B |
| Medy-Tox | 659.45B |
| MEDIPOST | 629.67B |
| Proteina | 488.45B |